Filters close
Newswise: Exploring Reproductive Factors and Gut Microbiome in Benign Breast Disease
Released: 7-Mar-2024 9:05 AM EST
Exploring Reproductive Factors and Gut Microbiome in Benign Breast Disease
Rutgers Cancer Institute of New Jersey

Tengteng Wang, PhD, MSPH, MBBS, cancer epidemiologist in the Section of Cancer Epidemiology and Health Outcomes at Rutgers Cancer Institute of New Jersey, has received more than $700,000 from the National Cancer Institute (R00CA267557) to support her research on examining the association between reproductive factors, gut microbiome, and benign breast disease (BBD).

Newswise:Video Embedded what-to-know-about-colorectal-cancer
VIDEO
Released: 6-Mar-2024 10:05 AM EST
What to Know About Colorectal Cancer
Rutgers Cancer Institute of New Jersey

Our GI cancer specialists perform the newest and most effective practices for diagnosing and treating pre-cancerous and cancerous conditions involving the colon. Dr. Pat Gulhati breaks down colorectal cancer and the advancements at Rutgers Cancer Institute, New Jersey's only NCI-designated Comprehensive Cancer Center.

Newswise:Video Embedded top-5-facts-to-know-about-kidney-cancer-with-dr-saum-ghodoussipour
VIDEO
Released: 6-Mar-2024 9:05 AM EST
Top 5 Facts to Know About Kidney Cancer with Dr. Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey

The kidneys are two bean-shaped organs located just below the rib cage, one on each side of your spine. Healthy kidneys filter blood to remove waste and extra water to make urine. Kidney cancer, also known as renal cell carcinoma or RCC, forms when healthy cells in one or both kidneys grow out of control. Learn more with Dr. Saum Ghodoussipour from Rutgers Cancer Institute of New Jersey.

Newswise: Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Retains its Position as New Jersey’s Only National Cancer Institute -Designated Comprehensive Cancer Center
Released: 5-Mar-2024 12:05 PM EST
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Retains its Position as New Jersey’s Only National Cancer Institute -Designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, the state’s leading cancer center and only Comprehensive Cancer Center as recognized by the National Cancer Institute (NCI), has scored in the “exceptional” range and was redesignated by the National Cancer Institute, placing it among the top cancer centers reviewed in 2023.

Newswise: Exploring Disparities in Colorectal Cancer
Released: 29-Feb-2024 12:05 PM EST
Exploring Disparities in Colorectal Cancer
Rutgers Cancer Institute of New Jersey

Howard S. Hochster, MD, FACP, director of the Gastrointestinal Oncology Program and Rutgers Cancer Institute of New Jersey Associate Director for Clinical Research and director of Oncology Research, RWJBarnabas Health shares his recommendations about keeping our attention focused on barriers to health care and preventive services and continuing to educate ourselves and others about colorectal cancer to reduce disparities.

Newswise: Insights into the Growing Incidence of Colorectal Cancer in Young Adults
Released: 29-Feb-2024 12:05 PM EST
Insights into the Growing Incidence of Colorectal Cancer in Young Adults
Rutgers Cancer Institute of New Jersey

Colorectal cancer (CRC) is on the rise in young adults. Incidences of colorectal cancer in young people (those between their mid-20s and late 50s) has more than doubled since the 1990s. Howard S. Hochster, MD, FACP, director of the Gastrointestinal Oncology Program and Rutgers Cancer Institute of New Jersey Associate Director for Clinical Research and director of Oncology Research, RWJBarnabas Health, shares his thoughts on this trend.

Newswise: Rutgers Women’s Basketball Partners with RWJBarnabas Health/Rutgers Cancer Institute and Kay Yow Cancer Fund to Establish the Rutgers Women’s Basketball Cancer Support Game Plan
Released: 19-Feb-2024 12:05 PM EST
Rutgers Women’s Basketball Partners with RWJBarnabas Health/Rutgers Cancer Institute and Kay Yow Cancer Fund to Establish the Rutgers Women’s Basketball Cancer Support Game Plan
Rutgers Cancer Institute of New Jersey

The Scarlet Knights presented a $50,000 check from the Kay Yow Cancer Fund to RWJBarnabas Health and Rutgers Cancer Institute of New Jersey to establish the Rutgers Women’s Basketball Cancer Support Game Plan, which will provide funding assistance for underserved female cancer patients across the State of New Jersey.

Newswise: $1.1M Grant Supports Research in Breast Cancer Survivorship among Black Women
Released: 6-Feb-2024 8:05 AM EST
$1.1M Grant Supports Research in Breast Cancer Survivorship among Black Women
Rutgers Cancer Institute of New Jersey

Bo (Bonnie) Qin, PhD, researcher and cancer epidemiologist in the Section of Cancer Epidemiology and Health Outcomes at Rutgers Cancer Institute of New Jersey, has received $1.1M from the American Cancer Society to support her research on the impact of lifestyle patterns, social determinants of health, and inflammatory mechanisms on breast cancer survivorship among Black women.

Newswise: Awards totaling $2.6 Million Support Exploration of Therapeutic Strategy for Adult and Pediatric T-cell Acute Lymphoblastic Leukemia
Released: 6-Feb-2024 8:05 AM EST
Awards totaling $2.6 Million Support Exploration of Therapeutic Strategy for Adult and Pediatric T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer Institute of New Jersey

Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program and only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, and associate professor of pharmacology and pediatrics at Rutgers Robert Wood Johnson Medical School, has received a total of $2.6M to support his research on acute lymphoblastic leukemia (ALL), an aggressive type of leukemia that affects both children and adults.

Newswise: Director of Oncology Services Northern Region Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 5-Feb-2024 9:30 AM EST
Director of Oncology Services Northern Region Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

George Raptis, MD, MBA, begins role at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health as director of Oncology Services for the Northern Region of New Jersey.

Newswise: RWJBarnabas Health and Rutgers Cancer Institute of New Jersey First in State offering Novel form of Liver Cancer Treatment
Released: 30-Jan-2024 2:05 PM EST
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey First in State offering Novel form of Liver Cancer Treatment
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, together with RWJBarnabas Health, has joined a select number of institutions nationwide that offer a specialized chemotherapy delivery system called hepatic artery infusion (HAI) therapy for patients with liver tumors.

Newswise: Rutgers Cancer Institute of New Jersey Unveils Leadership Enhancements for Next Era of Excellence
Released: 30-Jan-2024 1:05 PM EST
Rutgers Cancer Institute of New Jersey Unveils Leadership Enhancements for Next Era of Excellence
Rutgers Cancer Institute of New Jersey

To further support its mission and vision, Rutgers Cancer Institute of New Jersey has modified its leadership structure by elevating two associate director functions to deputy director positions.

Newswise: Experts Address the Latest on Cervical Cancer Treatment
Released: 25-Jan-2024 9:30 AM EST
Experts Address the Latest on Cervical Cancer Treatment
Rutgers Cancer Institute of New Jersey

Eugenia Girda, MD, FACOG, gynecologic oncologist in the Gynecologic Oncology Program at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health is lead author of a recent clinical practice statement exploring therapies for cervical cancer.

Newswise: $500K Grant Supports Exploration of Therapies for Difficult-to-Treat Lymphomas
Released: 8-Jan-2024 10:05 AM EST
$500K Grant Supports Exploration of Therapies for Difficult-to-Treat Lymphomas
Rutgers Cancer Institute of New Jersey

Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program and only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, and associate professor of pharmacology and pediatrics at Rutgers Robert Wood Johnson Medical School, has received a $500,000 collaborative grant from Gabrielle's Angel Foundation for Cancer Research and The Mark Foundation for Cancer Research.

Newswise: Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Showcase Expansive Portfolio of Hematology/Oncology Data at the 65th American Society of Hematology Annual Meeting and Exposition
Released: 28-Nov-2023 9:05 AM EST
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Showcase Expansive Portfolio of Hematology/Oncology Data at the 65th American Society of Hematology Annual Meeting and Exposition
Rutgers Cancer Institute of New Jersey

Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present an extensive array of hematology/oncology data from their clinical research program at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, being held in San Diego, California (and virtually) from December 9-12, 2023.

Newswise: New Chief of Cancer Survivorship Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 27-Nov-2023 1:05 PM EST
New Chief of Cancer Survivorship Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Louise Ligresti, MD, as chief of Cancer Survivorship at New Jersey’s leading cancer center and the only one in the state designated as a Comprehensive Cancer Center by the National Cancer Institute.

Newswise:Video Embedded rwjbarnabas-health-and-rutgers-cancer-institute-of-new-jersey-announce-transformative-investment-in-cancer-research-and-care
VIDEO
Released: 9-Nov-2023 10:05 AM EST
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey Announce Transformative Investment in Cancer Research and Care
Rutgers Cancer Institute of New Jersey

Elevating the combined strengths of the nationally recognized cancer center and the state’s largest academic health system will revolutionize care in New Jersey and beyond.

Newswise: Further Exploring T-cell Acute Lymphoblastic Leukemia: Rutgers Institute Researcher Awarded V Foundation for Cancer Research Grant
13-Oct-2023 1:05 PM EDT
Further Exploring T-cell Acute Lymphoblastic Leukemia: Rutgers Institute Researcher Awarded V Foundation for Cancer Research Grant
Rutgers Cancer Institute of New Jersey

Daniel Herranz Benito, PhD, PharmD, resident researcher at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, the state’s leading cancer program and only NCI-designated Comprehensive Cancer Center and assistant professor of pharmacology at Rutgers Robert Wood Johnson Medical School, has received $800,000 from the V Foundation for Cancer Research, a premier cancer research charity, to support his research on acute lymphoblastic leukemia (ALL).

Not for public release

This news release is embargoed until 3-Oct-2023 5:30 PM EDT Released to reporters: 28-Sep-2023 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Oct-2023 5:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Exploring Genetic Changes in Aggressive Pancreatic Cancer
28-Sep-2023 8:05 AM EDT
Exploring Genetic Changes in Aggressive Pancreatic Cancer
Rutgers Cancer Institute of New Jersey

Investigators from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, the state’s leading cancer program and only National Cancer Institute-designated Comprehensive Cancer Center, investigated genomic alterations based on KRAS status to identify mutations in patients with KRAS wild type (WT).

Newswise: Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Unveil Wide Range of Innovative Radiation Oncology Research at the 2023 ASTRO Annual Meeting
Released: 29-Sep-2023 6:05 PM EDT
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Unveil Wide Range of Innovative Radiation Oncology Research at the 2023 ASTRO Annual Meeting
Rutgers Cancer Institute of New Jersey

Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present new, novel, and expansive radiation oncology data from their clinical research program at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting, to be held in San Diego from October 1-4.

Newswise: Mammograms are Crucial to Women’s Health: Here’s why
Released: 28-Sep-2023 2:05 PM EDT
Mammograms are Crucial to Women’s Health: Here’s why
Rutgers Cancer Institute of New Jersey

While researchers continue to make advancements in cancer detection and treatment for breast cancer, one of the best ways to tackle the disease is through early detection and screening with mammography.

Newswise: Should I be Worried about Breast Cancer in my 20’s?
Released: 28-Sep-2023 2:05 PM EDT
Should I be Worried about Breast Cancer in my 20’s?
Rutgers Cancer Institute of New Jersey

What young women should know about breast cancer and screening.

Newswise:Video Embedded why-breast-cancer-clinical-trials-need-to-include-more-black-women
VIDEO
Released: 28-Sep-2023 2:05 PM EDT
Why Breast Cancer Clinical Trials Need to Include More Black Women
Rutgers Cancer Institute of New Jersey

Researchers are working to improve outcomes for Black women with breast cancer – including through increased participation in clinical trials, which helps find better ways to prevent, diagnose and treat cancer.

Newswise:Video Embedded expert-addresses-stigma-disparities-in-prostate-cancer
VIDEO
Released: 5-Sep-2023 3:05 PM EDT
Expert Addresses Stigma, Disparities in Prostate Cancer
Rutgers Cancer Institute of New Jersey

David M. Golombos, MD, addresses prostate cancer topics

Newswise: New Director of Cell Therapy and Bone Marrow Transplantation Northern Regions Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 14-Aug-2023 3:05 PM EDT
New Director of Cell Therapy and Bone Marrow Transplantation Northern Regions Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Adrienne Phillips, MD, MPH, as director of Cell Therapy and Bone Marrow Transplantation Northern Regions at New Jersey’s leading cancer program and only National Cancer Institute (NCI)- Designated Comprehensive Cancer Center.

Newswise: Rutgers Researchers Identify Lipid Vascular ‘ZIP code’
14-Aug-2023 12:30 PM EDT
Rutgers Researchers Identify Lipid Vascular ‘ZIP code’
Rutgers Cancer Institute of New Jersey

Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS), together with other collaborating groups, have discovered the first lipid vascular ‘ZIP code’ in the lungs, with implications for improved diagnostics and treatments, including patients with severe human respiratory diseases such as emphysema, COVID-19, COPD and lung cancer.

Newswise: New Chief of Pediatric Bone Marrow Transplantation and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 9-Aug-2023 10:15 AM EDT
New Chief of Pediatric Bone Marrow Transplantation and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Niketa C. Shah, MD, as chief of Pediatric Bone Marrow Transplantation and Cellular Therapies at New Jersey’s leading cancer program.

Newswise: Rutgers Cancer Institute of New Jersey Receives Grants to Support Ongoing Oncology Research
Released: 31-Jul-2023 11:40 AM EDT
Rutgers Cancer Institute of New Jersey Receives Grants to Support Ongoing Oncology Research
Rutgers Cancer Institute of New Jersey

Pilot awards, pre-doctoral fellowship awards and post-doctoral awards totaling $1.5 million were recently awarded to Rutgers Cancer Institute of New Jersey investigators by the New Jersey Commission on Cancer Research (NJCCR).

Newswise: 10 Quick Facts about Sarcoma, one of the Rarest Cancers
Released: 7-Jul-2023 2:20 PM EDT
10 Quick Facts about Sarcoma, one of the Rarest Cancers
Rutgers Cancer Institute of New Jersey

Sarcoma can be a difficult disease to detect and is often called ‘the forgotten cancer,’ that can grow in connective tissue like bones, nerves, muscles, tendons, cartilage and blood vessels of the arms and legs. It causes abdominal pain, lump, bone pain, and weight loss, and makes up approximately 1 percent of all adult cancer diagnoses. Understanding more about this disease can help people to identify it early. Learn more about Sarcoma in this blog.

Newswise: First New Jersey Patient Treated with Genetically Modified T-Cells Developed at state’s only National Cancer Institute-designated Comprehensive Cancer Center
Released: 5-Jul-2023 12:45 PM EDT
First New Jersey Patient Treated with Genetically Modified T-Cells Developed at state’s only National Cancer Institute-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey has treated its first patient using genetically modified T-cells that were manufactured in its own state-of-the-art Good Manufacturing Practices (GMP) facility.

Newswise: Highlighting Women Scientists: Rutgers Cancer Institute Researcher Awarded V Foundation for Cancer Research Grant
Released: 28-Jun-2023 3:05 PM EDT
Highlighting Women Scientists: Rutgers Cancer Institute Researcher Awarded V Foundation for Cancer Research Grant
Rutgers Cancer Institute of New Jersey

Christina Glytsou, PhD, member of the Cancer Metabolism and Immunology Cancer Pharmacology Program at Rutgers Cancer Institute of New Jersey, has received an award from The V Foundation for Cancer Research, a premier cancer research charity, to support her research on mitochondrial dynamics adaptations in drug-resistant acute myeloid leukemia.

Newswise: Breast Cancer Screening in Asian American & Pacific Islander Women in New Jersey
Released: 19-May-2023 10:05 AM EDT
Breast Cancer Screening in Asian American & Pacific Islander Women in New Jersey
Rutgers Cancer Institute of New Jersey

Recently, the United States Preventative Service Task Force released a draft recommendation statement on screening for breast cancer, recommending that all women get screened for breast cancer every other year starting at age 40. Rutgers Cancer Institute expert shares breast cancer data on the AAPI community.

Newswise: Enhancing Education for Care of Rare Pancreas Tumor
Released: 19-Apr-2023 8:05 AM EDT
Enhancing Education for Care of Rare Pancreas Tumor
Rutgers Cancer Institute of New Jersey

Oncology Nurses from Rutgers Cancer Institute of New Jersey share more on enhancing education for the care of patients with insulinoma, which will be presented as a poster at the ONS Annual Congress in San Antonio, Texas.

Newswise: $3.2 Million Grant Supports Study of New Genetic Testing Approach to Reduce Racial Health Disparities
Released: 30-Mar-2023 8:05 AM EDT
$3.2 Million Grant Supports Study of New Genetic Testing Approach to Reduce Racial Health Disparities
Rutgers Cancer Institute of New Jersey

With the aid of a near $3.2 million National Cancer Institute grant (R01CA277599) recently awarded, investigators from the state’s leading cancer program, Rutgers Cancer Institute of New Jersey,  and Georgetown University’s Lombardi Comprehensive Cancer Center, both NCI-designated Comprehensive Cancer Centers, will work to close racial disparity gaps in cancer care delivery by examining a novel approach to genetic testing and care based on community identified needs.

Newswise: Increase in Colorectal Cancer Among Younger Individuals Continues to Rise
Released: 28-Feb-2023 1:40 PM EST
Increase in Colorectal Cancer Among Younger Individuals Continues to Rise
Rutgers Cancer Institute of New Jersey

Expert from Rutgers Cancer Institute of New Jersey & RWJBarnabas Health discusses what young people should know about colorectal cancer as the disease continues to rise in those ranging in age from mid-20's to 50's.

Newswise: Spotlight on Rare Diseases: Gallbladder and Bile Duct Cancers
Released: 30-Jan-2023 4:35 PM EST
Spotlight on Rare Diseases: Gallbladder and Bile Duct Cancers
Rutgers Cancer Institute of New Jersey

Despite their rarity, it’s important to know the signs and symptoms of bile duct and gallbladder cancers.

Newswise: Cancer Survivors may be at Risk for Heart Disease
Released: 30-Jan-2023 11:05 AM EST
Cancer Survivors may be at Risk for Heart Disease
Rutgers Cancer Institute of New Jersey

The bottom line: before, during and after cancer treatment, heart health is critical. Andrew M. Evens, DO, MBA, MSc, associate director for Clinical Services at Rutgers Cancer Institute of New Jersey and medical director of the Oncology Service Line at RWJBarnabas Health, is a participating physician in the Cardio-Oncology Program at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program, in partnership with RWJBarnabas Health, shares more on the topic.

Newswise: Cancer Prevention Experts Provide Top Tips for Reducing Cancer Risk
Released: 30-Jan-2023 11:05 AM EST
Cancer Prevention Experts Provide Top Tips for Reducing Cancer Risk
Rutgers Cancer Institute of New Jersey

Elisa V. Bandera, MD, PhD and Carolyn J. Heckman, PhD, co-leaders of the Cancer Prevention and Control Research Program at Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, together with RWJBarnabas Health, share their top tips for cancer prevention during National Cancer Prevention Month.

Newswise: Investigators Explore Impact of Cigarette Smoking and Alcohol Consumption on Black Breast Cancer Survivors
20-Jan-2023 3:30 PM EST
Investigators Explore Impact of Cigarette Smoking and Alcohol Consumption on Black Breast Cancer Survivors
Rutgers Cancer Institute of New Jersey

In a new study published by JAMA Network Open, Dr. Elisa Bandera, Dr. Nur Zeinomar from Rutgers Cancer Institute of New Jersey and colleagues found that a higher risk of mortality in Black breast cancer survivors is associated with a history of cigarette smoking along with regular alcohol consumption at the time of diagnosis.



close
0.35432